BV02 is widely used in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a critical role in the development of drugs targeting neurological disorders, particularly in the treatment of conditions like Alzheimer's disease and Parkinson's disease. Its unique chemical structure allows it to interact effectively with specific enzymes and receptors in the brain, making it a valuable component in neuroprotective therapies.

In addition to its pharmaceutical applications, BV02 is utilized in research laboratories for studying biochemical pathways and mechanisms related to neurodegeneration. It serves as a reference compound in assays and experiments aimed at understanding the molecular basis of cognitive decline and motor function impairments. This contributes to the advancement of potential therapeutic strategies and drug discovery efforts.

Furthermore, BV02 has found use in the development of diagnostic tools. It is incorporated into imaging agents that help in the early detection and monitoring of neurodegenerative diseases. By enabling precise visualization of affected areas in the brain, it aids clinicians in making accurate diagnoses and tailoring treatment plans for patients.